Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
Abstract Introduction The JAK/STAT signaling pathway is involved in the immune-mediated inflammatory skin diseases atopic dermatitis (AD), vitiligo, and alopecia areata (AA), and represents a potential target when developing treatments. So far, no drugs targeting this pathway have been approved for...
Saved in:
Main Authors: | Ana M. Montilla (Author), Francisco Gómez-García (Author), Pedro J. Gómez-Arias (Author), Jesús Gay-Mimbrera (Author), Jorge Hernández-Parada (Author), Beatriz Isla-Tejera (Author), Juan Ruano (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alopecia areata after dupilumab for atopic dermatitis
by: Krystal Mitchell, MBA, et al.
Published: (2018) -
Association Between Scalp Microbiota Imbalance, Disease Severity, and Systemic Inflammatory Markers in Alopecia Areata
by: Pedro J. Gómez-Arias, et al.
Published: (2024) -
Selective JAK 1 inhibition with upadacitinib as a potential treatment for coexistent severe atopic dermatitis and alopecia areata,
by: Guilherme Muzy
Published: (2024) -
Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
by: Sung Kyung Cho, BA, et al.
Published: (2021) -
Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib
by: M. Pestana, et al.
Published: (2024)